Summary.-The cytotoxic effects in vivo of hydroxyurea (HU) on murine fibrosarcoma (FSa) cells grown as pulmonary tumours were determined. Tumour cells from 13-day-old nodules were made into suspension and separated on the basis of cell size by centrifugal elutriation. Flow microfluorometry (FMF) was used to determine the cell-cycle parameters and the relative synchrony of the separated populations, as well as the degree of contamination by normal diploid cells in each of the tumour-cell populations. HU cytotoxicity was tested by administering both a single 1 mg/g i.p. dose into mice that had been injected i.v. 20 min earlier with known numbers of synchronized viable FSa cells, and i.p. doses of 1 mg/g each into mice bearing 13-day-old pulmonary nodules. In the latter experiments, animals were killed 1 h after the last dose, and the tumour nodules were excised and made into a single-cell suspension and elutriated. Known numbers of cells from each fraction were injected into recipient mice to determine survival. In both sets of experiments, cell killing by HU correlated with the percentage of S-phase cells. The treatment of 13-day-old pulmonary nodules with 3 doses of HU also depleted the (G2+M) phase tumour cells and increased the heterogeneity between tumour subpopulations, as determined by FMF analysis.
MANY OF THE CHEMICAL AGENTS currently used in cancer therapy have phase-specific cytotoxicity. To evaluate these agents better before clinical trials, it would be advantageous to characterize their effectiveness on synchronized target cells within living animals. Recently, an in vivo method of studying the cell-cycle phase specific effects of a variety of chemotherapeutic agents in vivo was described (Grdina et al., 1979 (Grdina et al., , 1980 . Target tumour populations, enriched with cells in either G1, S or G2 + M phase by centrifugal elutriation, were injected i.v. into mice 20 min before the i.v., i.p., or s.c. administration of the drug to be tested. With the appropriate controls, the phasespecific cytotoxicity of any test agent could be determined (Grdina et al., 1979) . A limitation of this procedure, however, was the need for the inherent heterogeneity of the tumour-cell populations derived from solid tumours to be reduced for cell separation by centrifugal elutriation to be effective (Anderson et al., 1969; Grdina et al., 1978b) . This was accomplished by a 48h in vitro incubation (Grdina et al., 1978a) . To avoid this limitation, the method of centrifugal elutriation has been applied to separate murine fibrosarcoma (FSa) cells from pulmonary tumour nodules grown in C3H mice. Hydroxyurea (HU), because of its well characterized S-phase-specific cytotoxicity (Kim et al., 1967; Sinclair, 1967) , was chosen to demonstrate the applicability of this procedure to characterizing the in vivo effectiveness of phasespecific chemotherapeutic agents on advanced metastatic disease.
MATERIALS AND METHODS
Mice and tumour.-Female C3Hf/Kam mice, 10-12 weeks old, from our specific-pathogen-free breeding colony and a methycholanthrene-induced fibrosarcoma were used (Suit & Suchato, 1967) . Tumours, 6th-generation isotransplants, were made into viable single-cell suspensions and injected into untreated recipient mice to produce 100-150 pulmonary nodules (Grdina et al. 1978b ). After 13 days, tumour-bearing animals were killed, either immediately or after treatment with multiple doses of HU. Tumour cells derived from these pulmonary nodules were used in all the experiments.
Tumour-cell suspension.-Single-cell suspensions were prepared by mincing and trypsinizing colonies of tumour cells from excised lungs (Grdina et al., 1979) . Because no advantage was found from the careful excision of individual tumour nodules from surrounding lung tissue, cell suspensions were routinely made from entire lung lobes containing tumour tissue. Briefly, lung lobes, separated and removed from the surrounding viscera, were carefully minced with ophthalmic scissors. The mince, containing normal and tumour tissue, was added to a beaker containing 0.025% trypsin in Solution A (8.0g NaCl, 0-4g KCI, I Og glucose and 0 35 g NaHCO3 in a litre of water) and stirred on a magnetic stirrer for 20 min at room temperature. DNase (crude Deoxyribonuclease 1 from beef pancreas; Sigma Chemical Co., St Louis, MO) was also added to the mixture to achieve a final concentration of 0 1 mg/ml. After stirring, the beaker was allowed to stand undisturbed for 5 min. Highly enriched undigested tumour tissue settled to the bottom of the beaker, whereas most of the lung tissue floated to the top. While exercising care to avoid collecting floating lung tissue, the upper two-thirds of the suspension was removed and mixed with an equal volume of a modified McCoy's 5A growth medium supplemented with 20% foetal calf serum (Humphrey et al., 1970) . The stirring and collection procedure was repeated x 3. Each resultant suspension was passed through a stainless-steel mesh (200 wires/inch) and centrifuged at 225 g for 5 min. The supernatants were discarded, and the pellets were resuspended in McCoy's 5A supplemented with 5% FCS containing DNase at a final concentration of 0 1 mg/ml. Also included was 5mM 2-napthol 6-8 disulphonic acid to reduce cell clumping (Shortman, 1973) . After centrifugal elutriation, cell viability was Loutinely >95% as determined by phase-contrast microscopy.
Separation by centrifugal elutriation.-FSa cells derived from pulmonary nodules were separated under sterile conditions by centrifugal elutriation using the same procedure described for their separation from either solid tumours or tissue culture (Grdina et al., 1978a (Grdina et al., , 1979 . With the rotor speed set at 1525 rev/min, 2-3 x 108 cells, suspended in 20 ml of medium, were introduced into the elutriator chamber at a flow rate of 5 4 ml/min. The rotor speed was held constant throughout the separation, and the flow rates were varied by equal increments from 5*4 to 27-4 ml/min. Routinely, 12 fractions (F), each of 50 ml, were collected and stored at 4°C. Cells collected in each fraction were counted by haemacytometer and by Coulter Counter (model ZB1; Coulter Electronics, Hialeah, FL), and their volume distributions determined with a multichannel analyser (Channelyzer II; Coulter Electronics). The modal volume was designated as that corresponding to the modal channel number of the volume distribution of each sample (Grdina et al., 1978a) . F 1 containing small cells and cellular debris, and F 11 and 12, containing a heterogeneous mixture of cells, were discarded.
Flow microfluorometry. The DNA content of individual cells in suspension was determined by FMF using an ICP 11 flow cytometer (Phywe Co., Gottingen, Germany). cells were fixed in 70% ethanol and then stained with 50 mg/ml mithramycin (Mithracin; Pfizer and Co., Inc., New York, NY) in solution with MgCl2 (7 5 mM) and 12.5% aqueous ethanol (Grdina et al., 1978a) . The resultant histograms of DNA fluorescence were computer-analysed (Johnston et al., 1978) . Because cell suspensions were derived directly from FSa lung nodules, a considerable number of normal diploid lung cells were present in all the elutriator fractions. Since FSa cells are heteroploid (i.e., 60-70 chromosomes) and contain 1-8 as much DNA as normal diploid cells , an estimate of the normal cell contamination in each of the tumourcell suspensions can be made by determining the area under the G1 normal diploid peak and dividing it by the area under the total FMF histogram (i.e., the area under both the tumour and normal peaks) (Grdina et al., 1978a) . While the relative proportions of 4). J. GRDINA normal cells in the S and G2 + M phases contaminating FSa tumour-cell suspensions are uncertain (i.e., fluorescence from these cells would be detected at the same channels as those from G1 tumour cells), they are considered to be sufficiently rare in this experimental system to be ignored in these calculations. FMF histograms of lung cells from tumour-free animals indicate that less than 2 % of the cells are in S or G2 + M phases (unpublished data). Likewise, few if any diploid cells appear to be in the S phase in suspensions from pulmonary nodules (i.e., low background fluorescence in Channels 60 to 80, see Figs. 2 & 6) . Therefore all cell counts were adjusted after FMF analysis to represent only tumour-cell numbers.
Lung colony assay. (Grdina et al., 1979) . Twenty minutes after the injection of viable synchronized FSa cells, 10 of the 20 animals in each group were injected i.p. with a single dose of HU at 1I0 mg/g body wt. Thirteen days later the animals were killed, and the resulting colonies were counted. In Procedure B, mice bearing 13-day-old pulmonary nodules were injected i.p. each hour with 1 mg/g HU for 3 h (i.e., total dose 3 mg/g). One hour after the last injection, the animals were killed and their lungs removed. Suspensions of tumour cells were made and separated by centrifugal elutriation. The CFE of these cells was determined in a lung-colony assay with preconditioned mice.
RESULTS
The recovery of cells from centrifugal elutriation was routinely > 90% and the viability of these cells, determined by phase-contrast microscopy, was > 9500. The cell-killing of a single dose of HU on FSa cells lodged in the lungs of test animals (i.e., Procedure A) is presented in Fig. 4 . The CFE of both the control and treated populations was routinely corrected for normal-diploid-cell contamination. Cell killing with HU was most evident for FSa cells collected in F 6 and 7. These fractions contained the greatest concentrations of cells with S-phase DNA content. These data are consistent with the results using cultured FSa cells (Grdina et al., 1979) .
The cytotoxicity of 3 equal in vivo doses of HU at hourly intervals to FSa lung-nodule cells (i.e., Procedure B) is shown in Fig. 5 . Animals were killed 1 h after the last dose, lungs were removed and made into a single-cell suspension, and cells were separated by centrifugal elutriation. DNA histograms describing the separated tumour populations following HU treatment are presented in Fig. 6 . Whereas the fluorescence peaks representing normal diploid G1 cells remained unperturbed and comparable to those of untreated populations (Fig. 2) , those representing HU-treated G1 and (G2 + M) tumour cells are broader and more heterogeneous. Nevertheless, cell killing again correlated with the percentage of cells in S (see Fig. 5 ). A significant reduction in the percentage of cells with (G2 + M) DNA content was also found after this treatment, which is not surprising since the total treatment time was 4 h, and the duration of G2 + M FSa cells in vivo is only 2-8 h (Grdina, 1982) . The percentages of normal diploid G1 and tumour G1, 5, and (G2+M) cells, and the CVs of the G1 tumour fluorescence peaks are contained in Table II. 
DISCUSSION
Although centrifugal elutriation has been successfully used to separate and isolate populations of FSa tumour cells enriched in G1, S or (G2 + M) phases following growth in vitro (Grdina et al., 1978b (Grdina et al., , 1979 it has not been effective for synchronizing FSa cells derived directly from solid tumours growing in vivo (Grdina et al., , 1978b . The cellular parameter that is exploited using this procedure is cell volume, because the sedimentation rate of a cell is proportional to the twothirds power of its volume (Glick et al., 1971) . Cell size, under conditions of uniform growth, is known to increase during the division cycle (Anderson et al., 1969) . Thus, after exponential growth in vitro, the relationship between cell size and DNA content is readily exploitable for FSa tumour cells. In contrast, cells growing in solid tumours are exposed to a variety of physiological conditions, including variations in the availability of nutrients, 02 tension and pH. Consequently tumour cells of various sizes can have (Grdina et al., 1978a ). These differences cannot be explained solely by variations in the cell-cycle distribution of each of these populations; since FSa cell suspensions from pulmonary nodules and solid tumours exhibit similar DNA histograms by FMF analysis (Grdina et al., , 1978a evident for FSa cells collected in elutriator F 4-10. Tumour cells in the first 3 fractions, however, had a significantly reduced CFE, even after correction for normal cell contamination. The modal volume for cells in each of these fractions was <800 jUm3. The reduced CFE of these populations is consistent with results published in an earlier report on the reduced CFE of small (i.e., < 800 iUM3) FSa cells from solid tumours (Grdina et al., 1978b (Grdina et al., 1979) . HU was administered 20 min after tumour-cell injection in this procedure, because at this time > 950o of the injected cells are retained in the lungs (Grdina et al., 1978b) . As described in an earlier report, cell killing by HU was strongly correlated with the percentage of cells in S phase, as determined by FMF analysis (Fig. 4) .
The use of Procedure A for assessing the cycle-dependence of cytotoxic agents in vivo is predicated upon direct cell killing of target tumour cells. A phenomenon that could preclude the usefulness of this method would be a drug-mediated effect on the host response to the injected tumour cells that might selectively (i.e., as a function of their position within the division cycle), affect their clonogenic capacity. Two extremely effective agents that are known to enhance CFE of injected tumour cells are radiation and cyclophosphamide. However, using mice preconditioned with either of these agents, both lung-retention patterns of 1251-labelled FSa cells and the CFE of unlabelled cells were found not to vary with either cell size or position within the division cycle (Grdina et al., 1 978b) . Thus, under these conditions Procedure A remains an effective method for characterizing the relative in vivo phase specificity of cytotoxic agents such as HU. The usefulness of this procedure is confirmed by the close agreement between data acquired in this manner and those derived from established in vitro methods (Grdina et al., 1980; Mehn et al., 1980) . The S-phase-specific cytotoxicity of HU to FSa cells was also demonstrable after in situ treatment of 1 3-day-old tumour lung nodules (i.e., Procedure B; Fig. 6 ). Cell killing was again correlated with the fraction of cells in S phase. No reduction in cell recovery was evident, either in the preparation of cell suspensions or by centrifugal elutriation. Because the treatment time exceeded the duration of G2 +M (Grdina, 1982) it was not surprising that the proportion of cells in this phase was diminished. FMF analysis was made difficult, however, by the bimodal nature of the fluorescence peaks describing the DNA distributions of the tumour populations (Fig. 6) . This heterogeneity may have been due to a differential effect of HU on either the progression and killing and/or the stainability by mithramycin of cells in at least 2 distinct classes (i.e., with respect to DNA content) of FSa cells. Because of the relatively short exposure, it is unlikely that HU altered the DNA content of FSa cells. Rather, it is more likely that HU acted somehow to affect the stainability of a class of FSa cells by mithramycin. This phenomenon has been described in Chinese hamster ovary (cells treated with bromodeoxyuridine (Swartzendruber, 1977) . It is also interesting that the fluorescence peak describing the normal-diploid cells from each elutriator fraction was not affected by this treatment.
In conclusion, the phase-specific cytotoxicity of HU, administered in either a single-or multiple-dose schedule, on FSa cells from pulmonary nodules was described. In addition to measuring cytotoxicity, this procedure can be used to monitor and characterize perturbations in cell kinetics, both during and after therapeutic treatment. 
